The development of steroids-induced diabetes is based on the binding of GCs to their specific receptors that activate the hepatic production of glucose, inhibit the peripheric use of glucose, stimulate lipolysis in adipose tissue by activating hormone-sensitive lipase, and impair the pancreatic secretion of insulin, leading to insulin resistance [2]. The gene discussed is INS; the disease is diabetes mellitus.